CorMedix (CRMD)

• Market cap: $703M
• 1 day: 2.17%
• 5 days: 4.31%
• 1 month: 16.97%
• 3 months: 33.93%
• 6 months: -23.68%
• Year to date: -26.32%
• 1 year: -38.59%
• 5 years: 8.87%
• 10 years: -17.04%
• Sector: Healthcare
• Industry: Biotechnology

About: Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

Employees: 191